Alexandra Gruss

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 7

Top Topics

Genome Wide Association Study

Staphylococcus Aureus

Candida Albicans

Transcranial Magnetic Stimulation

Top Venues

Microbiology and molecular biology reviews : MMBR

Antimicrobial agents and chemotherapy

Journal of bacteriology

This page only lists publications with an associated author ORCID identifier.

Publications

Clara Lambert, Claire Poyart, Alexandra Gruss, Agnès Fouet
FabT, a Bacterial Transcriptional Repressor That Limits Futile Fatty Acid Biosynthesis. Microbiology and molecular biology reviews : MMBR 86 (3) (2022)
Constantin Hays, Clara Lambert, Sophie Brinster, Gilles Lamberet, Laurence du Merle, Karine Gloux, Alexandra Gruss, Claire Poyart, Agnès Fouet
Type II Fatty Acid Synthesis Pathway and Cyclopropane Ring Formation Are Dispensable during Enterococcus faecalis Systemic Infection. Journal of bacteriology 203 (20) (2021)
David Halpern, Claire Morvan, Aurélie Derré-Bobillot, Thierry Meylheuc, Mélanie Guillemet, Sylvie Rabot, Alexandra Gruss
Do Primocolonizing Bacteria Enable Bacteroides thetaiotaomicron Intestinal Colonization Independently of the Capacity To Consume Oxygen? mSphere 6 (3) (2021)
Bénédicte Cesselin, Céline Henry, Alexandra Gruss, Karine Gloux, Philippe Gaudu
Mechanisms of Acetoin Toxicity and Adaptive Responses in an Acetoin-Producing Species, Lactococcus lactis. Applied and environmental microbiology 87 (24) (2021)
Alexandra Gruss
A FAS solution to a DEAD case. PLoS genetics 16 (7) (2020)
Karine Gloux, Mélanie Guillemet, Charles Soler, Claire Morvan, David Halpern, Christine Pourcel, Hoang Vu Thien, Gilles Lamberet, Alexandra Gruss
Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus. Antimicrobial agents and chemotherapy 61 (5) (2017)
Claire Morvan, David Halpern, Gérald Kénanian, Constantin Hays, Jamila Anba-Mondoloni, Sophie Brinster, Sean Kennedy, Patrick Trieu-Cuot, Claire Poyart, Gilles Lamberet, Karine Gloux, Alexandra Gruss
Environmental fatty acids enable emergence of infectious Staphylococcus aureus resistant to FASII-targeted antimicrobials. Nature communications 7 (2016)